120 related articles for article (PubMed ID: 5520152)
1. [Immunological aspects of lung cancer].
Miquel Muse I; Klempert H; Mazzara R; Rodrĩguez Villamil J; Allo G; Korc I
Torax; 1970 Dec; 19(4):222-31. PubMed ID: 5520152
[No Abstract] [Full Text] [Related]
2. Immunoglobulins and complement components levels in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
[TBL] [Abstract][Full Text] [Related]
3. [Immuno-oncologic monitoring of patients with bronchial carcinoma. IV. Aspects of the immunocompetence system].
Mancuso M; Leonardo E; Sanfilippo B; Dogliotti C; De Simone M; De Bernochi P; Maggi G
Minerva Med; 1985 Mar; 76(13):619-26. PubMed ID: 3873024
[TBL] [Abstract][Full Text] [Related]
4. Immunocytology of cancer.
Davidsohn I; Ni LY
Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
[No Abstract] [Full Text] [Related]
5. [The diagnostic significance of the determination of SIgA in the sputum and saliva in lung cancer].
Chen TJ
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Dec; 8(6):325-7, 372. PubMed ID: 3836836
[No Abstract] [Full Text] [Related]
6. [The skin tests in operability evaluation of patients with non-small cell cancer of the lungs].
Biondo FG; Caldarelli L; Bergaminelli C; Perillo G
Arch Monaldi Mal Torace; 1988; 43(3):265-70. PubMed ID: 2855917
[No Abstract] [Full Text] [Related]
7. [Evaluation of immunological parameters during irradiation with combined chemotherapy in primary lung cancer (author's transl)].
Ogawa Y; Kimura S
Nihon Igaku Hoshasen Gakkai Zasshi; 1980; 40(4):341-54. PubMed ID: 7413433
[No Abstract] [Full Text] [Related]
8. E rosettes in the uranium miners with lung cancer.
Kudrna K; Andrlíková J; Smíd A; Stipl Z
Czech Med; 1979; 2(3):141-7. PubMed ID: 231508
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
Zółtowska A; Skokowski J; Mlekodaj S; Boj E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
[TBL] [Abstract][Full Text] [Related]
10. Immunocompetence in lung cancer patients: analysis of serological and cellular parameters.
Pierri I; Rogna S; Tavano A; Setti M; Scudeletti M; Ratto G; Motta G; Indiveri F
Cancer Detect Prev; 1988; 13(2):95-101. PubMed ID: 3242825
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic status in lung cancer].
Briusov PG; Polovoĭ AM
Sov Med; 1983; (3):16-9. PubMed ID: 6857368
[No Abstract] [Full Text] [Related]
12. [Activated cells in the peripheral blood in lung cancer].
Qian L
Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):18-21, 62. PubMed ID: 2848634
[No Abstract] [Full Text] [Related]
13. [Serum concentration of C3 in primary lung cancer patients].
Bariffi F; Marsico SA; Vigorito C; Alfani G; Donato Di Paola RM
Arch Monaldi; 1980; 35(4):169-74. PubMed ID: 6282231
[No Abstract] [Full Text] [Related]
14. Loss of isoantigens A, B, and H in carcinoma of the lung.
Davidsohn I; Ni LY
Am J Pathol; 1969 Nov; 57(2):307-34. PubMed ID: 4902573
[No Abstract] [Full Text] [Related]
15. [Immunogenic activity of the regional lymphoreticulum during primary cancer of the lung].
Lenzini L; Barnabé R
Folia Allergol (Roma); 1969; 16(6):524-34. PubMed ID: 5401365
[No Abstract] [Full Text] [Related]
16. [Immunoglobulin levels in the serum and bronchial washings in patients with lung cancer].
Pudelski J; Szczepański Z; Małecki S; Krzywiecki A; Cieślicki J; Wróbel-Lasok B
Pneumonol Pol; 1982 Dec; 50(12):661-7. PubMed ID: 6304660
[No Abstract] [Full Text] [Related]
17. [Haptoglobin system in lung cancer].
Ochmański W
Folia Med Cracov; 1979; 21(1):117-30. PubMed ID: 396186
[No Abstract] [Full Text] [Related]
18. [Statistical evaluation of globulin fractions in the course of malignant neoplasia].
Abeatici S; Lamarca S; Sassi I
Arch Sci Med (Torino); 1971; 128(4):231-5. PubMed ID: 5154435
[No Abstract] [Full Text] [Related]
19. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
Piacentini G; Ferrari S; Megale C; Ippoliti F
Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
[No Abstract] [Full Text] [Related]
20. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
